Becton Dickinson Pre-Tax Profit Margin 2010-2023 | BDX

Current and historical pre-tax profit margin for Becton Dickinson (BDX) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Becton Dickinson pre-tax profit margin for the three months ending December 31, 2023 was .
Becton Dickinson Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2023-12-31 $19.49B $1.54B 7.90%
2023-09-30 $19.37B $1.66B 8.58%
2023-06-30 $19.05B $1.80B 9.46%
2023-03-31 $18.81B $1.75B 9.31%
2022-12-31 $18.74B $1.66B 8.88%
2022-09-30 $18.87B $1.78B 9.45%
2022-06-30 $18.41B $1.32B 7.14%
2022-03-31 $18.38B $1.27B 6.92%
2021-12-31 $18.53B $1.14B 6.12%
2021-09-30 $19.13B $1.69B 8.84%
2021-06-30 $18.57B $1.41B 7.60%
2021-03-31 $17.82B $1.28B 7.19%
2020-12-31 $17.16B $1.18B 6.86%
2020-09-30 $16.07B $0.41B 2.58%
2020-06-30 $16.92B $0.84B 4.97%
2020-03-31 $17.41B $1.05B 6.05%
2019-12-31 $17.36B $0.86B 4.93%
2019-09-30 $17.29B $1.18B 6.80%
2019-06-30 $17.11B $1.59B 9.31%
2019-03-31 $17.04B $1.78B 10.44%
2018-12-31 $17.06B $1.78B 10.44%
2018-09-30 $15.98B $1.17B 7.34%
2018-06-30 $14.75B $1.08B 7.35%
2018-03-31 $13.50B $0.03B 0.24%
2017-12-31 $12.25B $0.39B 3.18%
2017-09-30 $12.09B $0.98B 8.07%
2017-06-30 $12.16B $0.66B 5.43%
2017-03-31 $12.32B $1.49B 12.06%
2016-12-31 $12.42B $1.50B 12.08%
2016-09-30 $12.48B $1.07B 8.60%
2016-06-30 $12.31B $1.25B 10.19%
2016-03-31 $12.23B $0.87B 7.12%
2015-12-31 $11.22B $0.72B 6.42%
2015-09-30 $10.28B $0.74B 7.19%
2015-06-30 $9.42B $0.93B 9.83%
2015-03-31 $8.46B $1.31B 15.48%
2014-12-31 $8.48B $1.45B 17.07%
2014-09-30 $8.45B $1.52B 18.02%
2014-06-30 $8.35B $1.21B 14.44%
2014-03-31 $8.24B $1.16B 14.09%
2013-12-31 $8.17B $1.16B 14.18%
2013-09-30 $8.05B $1.17B 14.46%
2013-06-30 $7.92B $1.47B 18.51%
2013-03-31 $7.85B $1.51B 19.19%
2012-12-31 $7.78B $1.52B 19.49%
2012-09-30 $7.71B $1.47B 19.09%
2012-06-30 $7.61B $1.46B 19.15%
2012-03-31 $7.58B $1.47B 19.43%
2011-12-31 $7.57B $1.53B 20.21%
2011-09-30 $7.58B $1.62B 21.32%
2011-06-30 $7.34B $1.59B 21.67%
2011-03-31 $7.22B $1.57B 21.73%
2010-12-31 $7.10B $1.55B 21.87%
2010-09-30 $7.12B $1.57B 22.00%
2010-06-30 $7.22B $1.62B 22.47%
2010-03-31 $7.21B $1.64B 22.73%
2009-12-31 $7.14B $1.58B 22.14%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $67.638B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $68.967B 18.46
West Pharmaceutical Services (WST) United States $27.235B 46.04
Cardinal Health (CAH) United States $26.315B 15.82
Align Technology (ALGN) United States $22.499B 45.37
Cooper (COO) United States $17.972B 27.19
Labcorp (LH) United States $16.950B 14.47
Henry Schein (HSIC) United States $9.104B 15.75
DENTSPLY SIRONA (XRAY) United States $6.325B 16.67
Merit Medical Systems (MMSI) United States $4.182B 23.93
Patterson (PDCO) United States $2.331B 11.17
STAAR Surgical (STAA) United States $2.267B 71.37
CONMED (CNMD) United States $2.237B 21.06
Atrion (ATRI) United States $0.708B 36.48
Lifevantage (LFVN) United States $0.086B 13.96
Pro-Dex (PDEX) United States $0.067B 25.33
Biolase (BIOL) United States $0.005B 0.00